[F15.—(1) If the applicant or holder gives notice under paragraph 4(1)(a) of his wish to appear before or be heard by a person appointed by the licensing authority, the authority shall—U.K.
(a)make that appointment; and
(b)arrange for the applicant or holder who gave notice to have an opportunity of appearing before the person appointed by the licensing authority.
(2) The person appointed—
(a)shall not be, or at any time have been, a member of—
(i)the Commission on Human Medicines or any of its Expert Advisory Groups,
(ii)the Medicines Commission formerly established under section 2 of the Act or any of its committees, or
(iii)a committee established under section 4 of the Act, or any sub-committee of such a committee; and
(b)shall not be an officer or servant of a Minister of the Crown.
(3) Subject to sub-paragraph (4), the applicant or holder shall provide the person appointed with—
(a)a written summary of the oral representations he intends to make; and
(b)any documents on which he wishes to rely in support of those representations,
before the end of the period of three months beginning with the date of the notice referred to in sub-paragraph (1).
(4) If the applicant or holder so requests, the person appointed may, after consulting the licensing authority, extend the time limit referred to in sub-paragraph (3), up to a maximum period of six months beginning with the date of the notice referred to in sub-paragraph (1).
(5) If the applicant or holder fails to comply with the time limit in sub-paragraph (3) or, where he has been granted an extended time limit under sub-paragraph (4), that time limit—
(a)he may not appear before or be heard by the person appointed; and
(b)the licensing authority shall decide whether to grant the authoriSation, revoke, vary or suspend the authorisation or confirm or alter their decision, as the case may be.
(6) The applicant or holder may not submit any additional written representations or documents once the time limit has expired, except with the permission of the person appointed.
(7) At the hearing before the person appointed, both the applicant or holder and the licensing authority may make representations.
(8) If the applicant or holder so requests the hearing shall be in public.
(9) After the hearing—
(a)the person appointed shall provide a report to the licensing authority; and
(b)the licensing authority shall take this report into account and decide whether to grant the authorisation, revoke, vary or suspend the authorisation or confirm or alter their decision, as the case may be.
(10) The licensing authority shall then—
(a)notify the applicant or holder of their decision;
(b)if the applicant or holder so requests, provide him with a copy of the report of the person appointed.]
Textual Amendments
F1Sch. 8 paras. 4, 5 substituted (30.10.2005) by The Medicines (Advisory Bodies) (No. 2) Regulations 2005 (S.I. 2005/2754), reg. 1(2)(b), Sch. 3 para. 6